Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Phase II Study of PX-12 in Patients With Advanced Pancreatic Cancer

This study has been terminated.
(Investigator decision)
Translational Genomics Research Institute, Phoenix, Arizona.
Information provided by (Responsible Party):
Oncothyreon Inc. Identifier:
First received: December 29, 2006
Last updated: March 21, 2013
Last verified: March 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2009
  Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)